John M. Yanni

Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: I. Assessment of Anti-Inflammatory Efficacy

Daniel A. Gamache, Gustav Graff, Milton T. Brady et al. · Inflammation · 2000 · 141 citations

Medicine, Ophthalmology, Pharmacotherapy +12

Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: II. In Vitro Bioactivation and Permeation of External Ocular Barriers

Tai-Lee Ke, Gustav Graff, Joan M. Spellman et al. · Inflammation · 2000 · 133 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.

Najam A. Sharif, S X Xu, Steven T. Miller et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 112 citations

Medicine, Medicinal Chemistry, Pharmacology +16

The <i>In Vitro</i> and <i>In Vivo</i> Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic Agent

John M. Yanni, D. J. Stephens, Steven T. Miller et al. · Journal of Ocular Pharmacology and Therapeutics · 1996 · 111 citations

Medicine, Ophthalmology, Pharmacology +16

Comparative Effects of Topical Ocular Anti-Allergy Drugs on Human Conjunctival Mast Cells

John M. Yanni, Steven T. Miller, Daniel A. Gamache et al. · Annals of Allergy Asthma & Immunology · 1997 · 103 citations

Medicine, Immunology, Ophthalmology +16